Yi-Bin Chen Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

3/2024	Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3.
1/2023	HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia.
1/2023	Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for IDH1-Mutated Acute Myeloid Leukemia.
12/2022	Eprenetapopt Plus Azacitidine After Allogeneic Hematopoietic Stem-Cell Transplantation for TP53-Mutant Acute Myeloid Leukemia and Myelodysplastic Syndromes.
11/2022	Enasidenib as maintenance following allogeneic hematopoietic cell transplantation for IDH2-mutated myeloid malignancies.
5/2021	Acute Myeloid Leukemia Presenting Less Than 3 Weeks After Living Donor Kidney Transplant: A Case Report.
1/2021	Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
1/2020	A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia.
1/2020	Current Approaches to Transplantation for FLT3-ITD AML.
1/2019	Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Bin Chen Research Topics

Disease

53	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024 - 09/2009
27	Neoplasms (Cancer) 04/2024 - 03/2010
25	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 11/2012
16	Lymphoma (Lymphomas) 12/2023 - 03/2013
14	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 06/2008
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2024 - 11/2009
12	Bronchiolitis Obliterans Syndrome 01/2024 - 04/2012
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 11/2009
10	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2022 - 02/2009
8	Hodgkin Disease (Hodgkin's Disease) 12/2022 - 07/2011
7	Infections 01/2023 - 10/2011
5	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 06/2008
5	Leukemia 12/2022 - 12/2015
4	Fever (Fevers) 12/2023 - 04/2014
4	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2020
3	Residual Neoplasm 12/2023 - 01/2019
3	Neutropenia 01/2022 - 01/2018
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 11/2019
2	Fatigue 01/2024 - 01/2021
2	Cytopenia 01/2023 - 01/2017
2	Mycoses (Diseases, Fungus) 01/2023 - 08/2013
2	Inflammation (Inflammations) 01/2022 - 12/2019
2	Carcinogenesis 12/2021 - 12/2020
2	Bacteremia 12/2020 - 11/2019
2	Multiple Myeloma 11/2019 - 07/2015
2	Mucositis 08/2017 - 01/2017
2	Bacterial Infections (Bacterial Infection) 08/2017 - 11/2009
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2013 - 04/2012
1	Hepatocellular Carcinoma (Hepatoma) 04/2024
1	Bites and Stings (Sting) 04/2024
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2024
1	Cytomegalovirus Infections (Inclusion Disease) 10/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023
1	Delirium 01/2023

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2017
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 11/2009
11	SteroidsIBA 03/2024 - 01/2017
9	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 06/2012
9	Busulfan (Busulfex)FDA Link 12/2017 - 11/2009
8	Tacrolimus (Prograf)FDA LinkGeneric 12/2022 - 09/2015
7	Sirolimus (Rapamycin)FDA Link 01/2020 - 07/2010
6	Rituximab (Mabthera)FDA Link 01/2023 - 11/2009
5	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2023 - 01/2012
5	Methotrexate (Mexate)FDA LinkGeneric 12/2022 - 09/2015
4	Chimeric Antigen ReceptorsIBA 12/2023 - 01/2019
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 11/2012
4	itacitinibIBA 01/2023 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 04/2024 - 12/2022
3	Natalizumab (Tysabri)FDA Link 12/2023 - 01/2021
3	pembrolizumabIBA 01/2023 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2016
3	Prednisone (Sone)FDA LinkGeneric 01/2023 - 05/2010
3	vedolizumabIBA 10/2021 - 01/2019
3	Monoclonal AntibodiesIBA 01/2021 - 11/2009
3	Brentuximab VedotinIBA 01/2020 - 01/2017
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 06/2013
3	fludarabineIBA 11/2019 - 06/2013
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2024 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 05/2010
2	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 05/2010
2	VaccinesIBA 12/2022 - 01/2022
2	ruxolitinibIBA 01/2022 - 11/2021
2	tisagenlecleucelIBA 01/2022 - 12/2019
2	Immunoconjugates (Immunoconjugate)IBA 01/2020 - 01/2018
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2019 - 03/2019
2	Bortezomib (Velcade)FDA Link 03/2019 - 01/2018
2	alpha-hydroxyglutarateIBA 01/2019 - 11/2012
2	Thomsen-Friedenreich antibodiesIBA 11/2018 - 12/2017
2	GlobulinsIBA 11/2018 - 12/2017
2	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 08/2013
2	fms-Like Tyrosine Kinase 3IBA 10/2016 - 12/2014
2	Sorafenib (BAY 43-9006)FDA Link 03/2016 - 12/2014
2	Tyrosine Kinase InhibitorsIBA 07/2013 - 04/2012
1	Mitochondrial DNA (mtDNA)IBA 04/2024
1	Cytotoxins (Cytolysins)IBA 04/2024
1	Arsenic Trioxide (Trisenox)FDA Link 04/2024
1	Circulating Tumor DNAIBA 04/2024
1	gilteritinibIBA 03/2024
1	Dihydrotachysterol (AT 10)IBA 01/2024
1	C-Reactive ProteinIBA 12/2023
1	letermovirIBA 10/2023
1	Peptides (Polypeptides)IBA 01/2023
1	LigandsIBA 01/2023
1	Antipsychotic Agents (Antipsychotics)IBA 01/2023

Therapy/Procedure

48	Therapeutics 04/2024 - 02/2009
48	Cell Transplantation 03/2024 - 09/2012
27	Stem Cell Transplantation 12/2023 - 09/2009
25	Hematopoietic Stem Cell Transplantation 01/2024 - 02/2009
18	Drug Therapy (Chemotherapy) 04/2024 - 11/2009
17	Transplantation 01/2023 - 11/2009
6	Homologous Transplantation 01/2021 - 02/2014
4	Kidney Transplantation 01/2022 - 11/2019
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2020 - 09/2014
2	Immunotherapy 04/2024 - 11/2014
2	Fecal Microbiota Transplantation 03/2024 - 11/2019
2	Blood Component Removal (Apheresis) 12/2023 - 12/2022
2	Salvage Therapy 01/2023 - 12/2019
2	Induction Chemotherapy 01/2020 - 01/2017
1	Aftercare (After-Treatment) 02/2024
1	Palliative Care (Palliative Therapy) 01/2024